Redeye provides an update following Senzime’s Q4 2025 report. Sales came in exactly in line with our estimates, and the deviation in EBIT was primarily due to a non-cash inventory write-down and one-off items in OPEX. Overall, we view the report as solid, highlighting that Senzime is moving in the right direction, and we expect a strong 2026. In this update, we have made some downward sales estimate changes, primarily FX-driven, and have fine-tuned our OPEX assumptions. These changes result in an updated fair value range.
LÄS MER
